FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076759789> ?p ?o ?g. }

• W2076759789 endingPage "833" @default.
• W2076759789 startingPage "827" @default.
• W2076759789 abstract "Rationale and Objectives The aim of this study was to determine the clinicopathologic significance of high-intensity areas in the ureter, urethra, prostate, and bone incidentally found on diffusion-weighted magnetic resonance imaging (DWI) for the staging of bladder cancer. Materials and Methods Axial and sagittal DWI and T2-weighted imaging of the pelvis were evaluated in 157 patients with bladder cancer. Two observers assessed T2-weighted imaging with DWI independently. The observers pointed out 67 areas showing abnormal high signal intensity on DWI in the ureter (n = 17), urethra (n = 8), prostate (n = 20), and bone (n = 22). Of the 67 high-intensity areas, 33 lesions were confirmed histopathologically (ureter, n = 10; urethra, n = 7; prostate, n = 16), and 22 bone lesions were diagnosed using T1-weighted imaging and follow-up computed tomography. Thus, 55 lesions were evaluable for correlation with DWI findings. Results Of the 55 high-intensity areas, 28 (53%) were synchronous or metastatic urothelial cancer or invasion of urothelial cancer. The remaining 27 (47%) were a ureteral clot in one, a ureteral stone granuloma in one, prostatic cancer in six, granulomatous prostatitis in three, and normal red bone marrow in 16. Conclusions DWI is useful to comprehend the extent of bladder cancer and to detect incidentally coexisting diseases. Other imaging, endoscopic, and clinical findings would be useful to reduce false positivity. The aim of this study was to determine the clinicopathologic significance of high-intensity areas in the ureter, urethra, prostate, and bone incidentally found on diffusion-weighted magnetic resonance imaging (DWI) for the staging of bladder cancer. Axial and sagittal DWI and T2-weighted imaging of the pelvis were evaluated in 157 patients with bladder cancer. Two observers assessed T2-weighted imaging with DWI independently. The observers pointed out 67 areas showing abnormal high signal intensity on DWI in the ureter (n = 17), urethra (n = 8), prostate (n = 20), and bone (n = 22). Of the 67 high-intensity areas, 33 lesions were confirmed histopathologically (ureter, n = 10; urethra, n = 7; prostate, n = 16), and 22 bone lesions were diagnosed using T1-weighted imaging and follow-up computed tomography. Thus, 55 lesions were evaluable for correlation with DWI findings. Of the 55 high-intensity areas, 28 (53%) were synchronous or metastatic urothelial cancer or invasion of urothelial cancer. The remaining 27 (47%) were a ureteral clot in one, a ureteral stone granuloma in one, prostatic cancer in six, granulomatous prostatitis in three, and normal red bone marrow in 16. DWI is useful to comprehend the extent of bladder cancer and to detect incidentally coexisting diseases. Other imaging, endoscopic, and clinical findings would be useful to reduce false positivity." @default.
• W2076759789 created "2016-06-24" @default.
• W2076759789 creator A5005006572 @default.
• W2076759789 creator A5016484890 @default.
• W2076759789 creator A5059868927 @default.
• W2076759789 creator A5064249119 @default.
• W2076759789 creator A5070315642 @default.
• W2076759789 creator A5071240286 @default.
• W2076759789 creator A5075393386 @default.
• W2076759789 creator A5086194342 @default.
• W2076759789 creator A5091149024 @default.
• W2076759789 date "2012-07-01" @default.
• W2076759789 modified "2023-09-26" @default.
• W2076759789 title "Clinicopathologic Significance of High Signal Intensity on Diffusion-weighted MR Imaging in the Ureter, Urethra, Prostate and Bone of Patients with Bladder Cancer" @default.
• W2076759789 cites W1979703813 @default.
• W2076759789 cites W1985116091 @default.
• W2076759789 cites W1995844238 @default.
• W2076759789 cites W2006426323 @default.
• W2076759789 cites W2017549161 @default.
• W2076759789 cites W2027309931 @default.
• W2076759789 cites W2061732819 @default.
• W2076759789 cites W2067257549 @default.
• W2076759789 cites W2077882972 @default.
• W2076759789 cites W2080383799 @default.
• W2076759789 cites W2085026600 @default.
• W2076759789 cites W2085570666 @default.
• W2076759789 cites W2086141729 @default.
• W2076759789 cites W2088488036 @default.
• W2076759789 cites W2096643132 @default.
• W2076759789 cites W2102125723 @default.
• W2076759789 cites W2111561642 @default.
• W2076759789 cites W2115887117 @default.
• W2076759789 cites W2120305803 @default.
• W2076759789 cites W2125112438 @default.
• W2076759789 cites W2133567801 @default.
• W2076759789 cites W2138600626 @default.
• W2076759789 cites W2150795960 @default.
• W2076759789 cites W2230855427 @default.
• W2076759789 cites W2414380551 @default.
• W2076759789 cites W2486027786 @default.
• W2076759789 doi "https://doi.org/10.1016/j.acra.2012.01.013" @default.
• W2076759789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22341371" @default.
• W2076759789 hasPublicationYear "2012" @default.
• W2076759789 type Work @default.
• W2076759789 sameAs 2076759789 @default.
• W2076759789 citedByCount "21" @default.
• W2076759789 countsByYear W20767597892013 @default.
• W2076759789 countsByYear W20767597892014 @default.
• W2076759789 countsByYear W20767597892015 @default.
• W2076759789 countsByYear W20767597892016 @default.
• W2076759789 countsByYear W20767597892017 @default.
• W2076759789 countsByYear W20767597892019 @default.
• W2076759789 countsByYear W20767597892020 @default.
• W2076759789 countsByYear W20767597892022 @default.
• W2076759789 crossrefType "journal-article" @default.
• W2076759789 hasAuthorship W2076759789A5005006572 @default.
• W2076759789 hasAuthorship W2076759789A5016484890 @default.
• W2076759789 hasAuthorship W2076759789A5059868927 @default.
• W2076759789 hasAuthorship W2076759789A5064249119 @default.
• W2076759789 hasAuthorship W2076759789A5070315642 @default.
• W2076759789 hasAuthorship W2076759789A5071240286 @default.
• W2076759789 hasAuthorship W2076759789A5075393386 @default.
• W2076759789 hasAuthorship W2076759789A5086194342 @default.
• W2076759789 hasAuthorship W2076759789A5091149024 @default.
• W2076759789 hasConcept C121608353 @default.
• W2076759789 hasConcept C126322002 @default.
• W2076759789 hasConcept C126838900 @default.
• W2076759789 hasConcept C126894567 @default.
• W2076759789 hasConcept C143409427 @default.
• W2076759789 hasConcept C2776235491 @default.
• W2076759789 hasConcept C2776664737 @default.
• W2076759789 hasConcept C2777085111 @default.
• W2076759789 hasConcept C2777957205 @default.
• W2076759789 hasConcept C2780192828 @default.
• W2076759789 hasConcept C2780352672 @default.
• W2076759789 hasConcept C71924100 @default.
• W2076759789 hasConceptScore W2076759789C121608353 @default.
• W2076759789 hasConceptScore W2076759789C126322002 @default.
• W2076759789 hasConceptScore W2076759789C126838900 @default.
• W2076759789 hasConceptScore W2076759789C126894567 @default.
• W2076759789 hasConceptScore W2076759789C143409427 @default.
• W2076759789 hasConceptScore W2076759789C2776235491 @default.
• W2076759789 hasConceptScore W2076759789C2776664737 @default.
• W2076759789 hasConceptScore W2076759789C2777085111 @default.
• W2076759789 hasConceptScore W2076759789C2777957205 @default.
• W2076759789 hasConceptScore W2076759789C2780192828 @default.
• W2076759789 hasConceptScore W2076759789C2780352672 @default.
• W2076759789 hasConceptScore W2076759789C71924100 @default.
• W2076759789 hasIssue "7" @default.
• W2076759789 hasLocation W20767597891 @default.
• W2076759789 hasLocation W20767597892 @default.
• W2076759789 hasOpenAccess W2076759789 @default.
• W2076759789 hasPrimaryLocation W20767597891 @default.
• W2076759789 hasRelatedWork W1560413449 @default.
• W2076759789 hasRelatedWork W2039171803 @default.
• W2076759789 hasRelatedWork W2086200972 @default.
• W2076759789 hasRelatedWork W2092693552 @default.
• W2076759789 hasRelatedWork W2126197145 @default.

• next